Merck & Co Inc [NYSE: MRK] loss -0.82% on the last trading session, reaching $130.12 price per share at the time. If compared to the average trading volume of 8.43M shares, MRK reached a trading volume of 6787997 in the most recent trading day, which
Merck & Co Inc [NYSE: MRK] gained 0.92% or 1.16 points to close at $126.94 with a heavy trading volume of 7805754 shares. The daily chart for MRK points out that the company has recorded 26.40% gains over the past six months. If we look
Merck & Co Inc [NYSE: MRK] price surged by 0.36 percent to reach at $0.45. The one-year MRK stock forecast points to a potential upside of 8.2. The average equity rating for MRK stock is currently 1.55, trading closer to a bullish pattern in the
Merck & Co Inc [NYSE: MRK] loss -1.12% or -1.43 points to close at $126.56 with a heavy trading volume of 6282092 shares. The company report on April 4, 2024 at 6:45 AM that Merck Initiates Phase 3 Clinical Trial of MK-1084, an Investigational Oral
Merck & Co Inc [NYSE: MRK] price surged by 0.15 percent to reach at $0.2. The company report on March 28, 2024 at 9:15 AM that How We Can Strengthen Vaccination Programs and Build Vaccine Confidence Together. Two Merck leaders share how their company is
Merck & Co Inc [NYSE: MRK] closed the trading session at $125.52. The stocks have a year to date performance of 15.13 percent and weekly performance of 2.72 percent. The stock has been moved at 18.59 percent over the last six months. The stock has
Merck & Co Inc [NYSE: MRK] gained 0.84% or 1.01 points to close at $121.52 with a heavy trading volume of 46427874 shares. The company report on March 15, 2024 at 4:23 PM that FarmSee Ltd Announces the Completion of a Minority Investment in its
Merck & Co Inc [NYSE: MRK] price plunged by -0.59 percent to reach at -$0.73. The company report on March 11, 2024 at 8:15 AM that Merck Completes Acquisition of Harpoon Therapeutics, Inc. Acquisition broadens oncology pipeline with a portfolio of novel T-cell engagers including
Merck & Co Inc [NYSE: MRK] stock went on a downward path that fall over -2.29% on Monday, amounting to a one-week price decrease of less than -3.72%. The company report on March 4, 2024 at 6:45 AM that Merck to Participate in the Leerink
Merck & Co Inc [NYSE: MRK] traded at a high on Tuesday, posting a 0.15 gain after which it closed the day’ session at $129.03. The company report on February 27, 2024 at 6:45 AM that Merck to Participate in the TD Cowen 44th Annual
© 2024, Powered by Smart TechOne
